New data show safety of Pfizer COVID vaccine for teenagers

New data show safety of Pfizer COVID vaccine for teens ages 12 to 17 Very few serious adverse events were reported, and instances of myocarditis were lower than initially reported. CIDRAP

...Pediatrics researchers published the safety data of the Pfizer-BioNTech (BNT-162b2) COVID-19 vaccine in adolescents ages 12 to 17 years. After 1 year, very few serious adverse events were reported, and instances of myocarditis (inflammation of heart muscle) were lower than initially reported.

...